Week in Review: December 15–19

Reprogramming questioned; dengue-detecting antibodies; drug repurposing for Ebola; transcription of retroviruses

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FANJIE MENG Manipulating mechanical forces alone can prompt somatic cells toward a stem cell-like state, according to researchers at the University of Buffalo in New York. Their work, published in PNAS last month (November 24), is reminiscent of the stimulus-triggered acquisition of pluripotency (STAP) papers, which were published in January and retracted in July.

Paul Knoepfler, a stem cell biologist at the University of California, Davis, who was not involved in either project raised questions about this latest work. “I’m concerned in this paper and, more broadly, that the term ‘reprogramming’ is being used too loosely and without definitive evidence,” he told The Scientist.

EMBL-EBI, WANWISA DEJNIRATTISAI ET AL.A team led by investigators at Imperial College London has identified antibodies that recognize an envelope protein unique to dengue virus. The work, published in Nature Immunology this week (December 15), could inform future vaccine development efforts.

“What [our study] suggests is that it is potentially possible to provide cross-reactive immunity, and furthermore it means that we might be able to raise immunity against dengue using recombinant protein,” said study coauthor Gavin Screaton of Imperial College.

WIKIMEDIA, BRUCEBLAUSTI-2 antigens may stimulate the transcription of normally silent retroviral sequences in B cells, researchers from the University of Texas Southwestern Medical Center and their colleagues reported in Science this week (December 18). The retroviral expression in turn spurs B-cell proliferation and increased production of antibodies.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo